asa guidelines for glp 1 drugs Anesthetic Considerations Patients Taking Glucagon-Like Peptide-1 Agonists Glucagon-Like Peptide-1 Receptor Agonists in
Description
Research continues, but immediate approval in this indication now appears unlikely

Researchers have proposed several theories: GLP-1 Receptors in the Optic Nerve The optic nerve does have GLP-1 receptors, meaning the drugs may act directly
[DOI] [PMC free article] [PubMed] [Google Scholar] 72.Seferovic P.M., Petrie M.C., Filippatos G.S., Anker S.D., Rosano G., Bauersachs J., Paulus W.J., Komajda M., Cosentino F., de Boer R.A., et al

The primary risk during sedation or anesthesia is aspiration: stomach contents entering the lungs if vomiting or regurgitation occurs, which can lead to serious complications like pneumonia or respiratory distress

Some are taken twice daily, some extended-release (ER) weekly, and others once daily

GLP-1 receptor agonists like tirzepatide are already prescribed for diabetes and weight management
